| Patient | Theodore Roosevelt |
|---|---|
| Date of birth | 1858-10-27 |
| Identifiers | MRN HR-NI012-SYN-TD; SSN (made up) 000-12-6157 |
| Document date | 1882-09-14 |
| Author | Amos Kettering, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month asthma review after a summer exacerbation. [S]
Mr. Roosevelt returns for his six-month review. Six weeks ago he had a moderate exacerbation with a cold, treated at a same-day visit with five days of prednisone 40 mg. The nurse telephone check three days later found his peak flow back above 500 L/min. He was not seen in clinic within the week afterwards, as his plan advised, because the appointment was never booked. He recovered fully within ten days and returned to training after two weeks. Since then he has had no night waking, no daytime symptoms apart from before training, and peak flows of 580 to 610 L/min. He takes every maintenance dose. [S]
| Element | Detail |
|---|---|
| Interval history | Moderate exacerbation with a cold six weeks ago; five days of prednisone; full recovery |
| Post-exacerbation follow-up | Telephone check at three days; no clinic review within one week |
| Reliever use | One inhalation before training; none otherwise |
| Home peak flow | 580 to 610 L/min |
| Adherence | Full |
| Exacerbations in the past 12 months | Two oral corticosteroid courses: one last winter before controller therapy and one six weeks ago |
| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No cough, wheeze, or night symptoms |
| Constitutional | Negative | No fever; energy back to normal |
| Endocrine | Negative | No thirst, sleep disturbance, or mood change after the prednisone course |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 mcg/actuation inhaler, two inhalations as needed for wheeze (bought after an urgent care visit; used most days before intake) | Two inhalations every 4 hours as needed | Respiratory tract route | 1881-12-15 to 1882-03-09 | stopped | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance | Two inhalations twice daily, with a spacer, rinsing the mouth afterwards | Respiratory tract route | 1882-03-09 | active | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total | One inhalation as needed, repeated after a few minutes if needed; maximum 12 inhalations a day including maintenance doses | Respiratory tract route | 1882-03-09 | active | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 days | Two tablets by mouth each morning for 5 days | Oral route | 1882-08-03 to 1882-08-07 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1882-09-14 | Body height | 175 | cm | S |
| 1882-09-14 | Body weight | 73.2 | kg | S |
| 1882-09-14 | Body mass index (BMI) [Ratio] | 23.9 | kg/m2 | S |
| 1882-09-14 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1882-09-14 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1882-09-14 | Heart rate | 68 | /min | S |
| 1882-09-14 | Respiratory rate | 14 | /min | S |
| 1882-09-14 | Body temperature | 36.7 | Cel | S |
| 1882-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1882-09-14 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 590 | L/min | 80 percent or more of his personal best of 610 L/min (green zone) | Normal | S |
| 1882-09-14 | Total score [ACT] | 21 | {score} | S |
Vital signs recorded on 1882-09-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Mouth | No thrush |
| Lungs | Clear |
| Inhaler technique | Correct with his own inhaler and spacer |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthma | active | confirmed | J45.40 | S — Synthetic modern classification confirmed by spirometry; the historical asthma is D and its persistence into adulthood is R. |
| Myopia, both eyes, corrected with glasses since boyhood | active | confirmed | H52.13 | S — Synthetic modern entry linked to his documented near-sightedness. |
| Moderate asthma exacerbation triggered by a viral cold, treated in the office with a five-day prednisone course; resolved | resolved | confirmed | J45.41 | S — Synthetic exacerbation at an unscheduled visit; viral infection is the most common trigger of asthma exacerbations. It does not echo a dated historical episode. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Asthma Control Test | Every visit | Completed today | 21, well controlled |
| Examination | Peak flow | Daily or with symptoms for moderate to severe asthma | Completed today | 590 L/min, green zone |
| Examination | Inhaler technique with his own device | Every visit | Completed today | Correct |
| Medication safety | Adherence and reliever use | Every visit | Completed today | Full adherence; reliever before training only |
| Survey | Exacerbation history | Every visit | Completed today | One oral corticosteroid course since starting controller therapy, six weeks ago, with a viral cold; no emergency visits or hospital stays |
| Survey | Clinic review within one week of an exacerbation | Within 1 week of any exacerbation | Deferred | Missed: advised at the sick visit but never booked, a deviation from the protocol; only the day-three nurse telephone check took place. No harm resulted: he recovered fully, and today's control and peak flow are good. Corrective action: post-exacerbation reviews are now booked at the sick visit before the patient leaves |
| Self-management | Written asthma action plan | Every visit and after every exacerbation | Completed today | Reviewed and updated after the exacerbation |
| Self-management | Trigger and exposure review, smoking and vaping status | Every visit | Completed today | Viral colds remain his main trigger; never smoker |
| Survey | Step-up or step-down assessment | Every visit | Completed today | No change: step-down deferred because of the recent exacerbation; step-up not needed with good control, adherence, and technique |
| Examination | Spirometry | At diagnosis, 3 to 6 months after stabilization, then every 1 to 2 years | Up to date | Normal three months ago; next in one to two years |
| Referral | Biologic candidacy assessment | Only if severe and uncontrolled despite optimized Step 4 to 5 therapy | Not indicated | One exacerbation on controller therapy, with good control between; criteria for severe asthma not met |
| Medication safety | Vaccination status | Yearly | Due | Influenza vaccine planned at next month's preventive visit |
Goal progress:
Guideline basis: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026)
Follow-up: Preventive visit next month. Asthma review in three months, or within one week of any exacerbation. Next scheduled visit 1882-10-19: periodic adult preventive visit. [S]